ArticleCureus2021

Comparison of Efficacy and Safety Profile of Sodium-Glucose Cotransporter-2 Inhibitors as Add-On Therapy in Patients With Type 2 Diabetes.

Mazhar Hussain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.